Medidata AI Supports PPD’s $60M Study Award in Rare Oncology Indication

PPD, Thermo Fisher’s clinical research business, partnered with Medidata AI Intelligent Trials to leverage broad industry performance data to more accurately forecast patient enrollment rates.  Medidata AI & PPD reduced the projected clinical trial timeline and was awarded a key $60M study in a rare oncology indication.

Learn more about Medidata AI Intelligent Trials

Medidata AI Intelligent Trials offers insights across the study life cycle from study planning to execution, leveraging Medidata’s industry-leading historical clinical trial data repository of more than 9 million patients from 30,000 clinical trials to provide an integrated view of site performance and demographic data. With this solution, pharmaceutical companies and CROs can gain confidence in decision making, visibility into trial and industry performance, and agility to navigate a dynamic trial landscape and gain a competitive edge – all to help bring treatments to patients faster.